Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer Cells

Area of Science:

• Endocrinology
• Molecular Biology
• Cancer Research

Background:

• Sex Hormone Binding Globulin (SHBG) primarily functions as a serum carrier for sex hormones.
• Emerging evidence indicates SHBG internalization and intracellular roles in hormone action regulation.
• The androgen-sensitive LNCaP prostate cancer cell line is a relevant model for studying testosterone's effects.

Purpose of the Study:

• To investigate the role of SHBG in testosterone uptake, metabolism, and action within LNCaP prostate cancer cells.
• To assess the impact of SHBG internalization on intracellular testosterone signaling pathways.
• To determine SHBG's influence on androgen-responsive gene expression and prostate cancer cell proliferation.

Main Methods:

• Assessed internalization of SHBG and testosterone in LNCaP cells.
• Quantified testosterone uptake and metabolism, including glucuronide formation.
• Measured expression of androgen-responsive genes (e.g., prostate specific antigen, androgen receptor mRNA).
• Evaluated effects of SHBG and testosterone on cell morphology and growth.

Main Results:

• LNCaP cells demonstrated testosterone-independent SHBG internalization.
• SHBG presence reduced testosterone efflux as testosterone-glucuronide.
• SHBG enhanced testosterone-induced prostate specific antigen expression and androgen receptor mRNA reduction.
• SHBG counteracted testosterone's inhibitory effects on cell morphology and growth.

Conclusions:

• Internalized SHBG plays a significant intracellular regulatory role in modulating testosterone action.
• SHBG influences testosterone bioavailability and signaling within prostate cancer cells.
• These findings highlight the complex role of SHBG in both normal physiology and disease states.